MESO

Mesoblast Limited

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$13.1

Price (1 Year)

$20.96 $12.28

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %9.3 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %8.9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.

Website

Analysis (Turkish): MESO Hissesi Caiz mi, Helal mi? Mesoblast Limited Katılım Analizi